Showing results (91-100 of 317) with videos related to

Sort By:
Pageof 32
Cells|April 10, 2019
Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast CancerNavid Sobhani, Alberto D'Angelo, Matteo Pittacolo, et al.
World Neurosurgery|December 12, 2022
Posterior Petrous Meningiomas: Surgical Classification and Postoperative Outcomes in a Case Series of 130 Patients Operated via the Retrosigmoid ApproachCarmine Antonio Donofrio, Filippo Badaloni, Lucia Riccio, et al.
Seminars in Oncology Nursing|November 21, 2025
Meaning, Identity, and Practice in Nipple-Areola Complex Tattooing Among Breast Cancer Survivors: A Scoping Review With a Data Mining ApproachMattia Bozzetti, Alessio Lo Cascio, Daniele Napolitano, et al.
Clinical and Experimental Medicine|April 10, 2017
Are EGFR tyrosine kinase inhibitors effective in elderly patients with EGFR-mutated non-small cell lung cancer?Giandomenico Roviello, Laura Zanotti, Maria Rosa Cappelletti, et al.
Journal of Cancer Research and Clinical Oncology|January 19, 2018
Benefit of the addition of hormone therapy to neoadjuvant anthracycline-based chemotherapy for breast cancer: comparison of predicted and observed pCRDaniele Generali, Silvia Paola Corona, Lajos Pusztai, et al.
European Journal of Cancer (Oxford, England : 1990)|April 14, 2022
Treatment response and 5-year distant metastasis-free survival outcome in breast cancer patients after the use of MammaPrint and BluePrint to guide preoperative systemic treatment decisionsEmine Göker, Mathijs P Hendriks, Marc van Tilburg, et al.
Frontiers in Oncology|January 8, 2024
Aromatase inhibitors: the journey from the state of the art to clinical open questionsDaniele Generali, Rossana Berardi, Michele Caruso, et al.
Expert Review of Anticancer Therapy|May 22, 2018
Combination therapies for the treatment of HER2-positive breast cancer: current and future prospectsMariana Brandão, Noam F Pondé, Francesca Poggio, et al.
Frontiers in Oncology|November 22, 2021
BRAF Signaling Inhibition in Glioblastoma: Which Clinical Perspectives?Victoria Bouchè, Giovanni Aldegheri, Carmine Antonio Donofrio, et al.
Frontiers in Oncology|February 8, 2024
Corrigendum: Aromatase inhibitors: the journey from the state of the art to clinical open questionsDaniele Generali, Rossana Berardi, Michele Caruso, et al.
Pageof 32